Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |
mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.12 | 0.005 |
mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.14 | 0.005 |
mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |